卵巢透明细胞癌-话题@MedSci

#卵巢透明细胞癌#

7篇内容 | 714人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2174216, encodeId=a9b421e421605, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#贝伐珠单抗#</a> <a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a> <a href='/topic/show?id=5c4b1084e6b5' target=_blank style='color:#2F92EE;'>#帕米帕利#</a>, objectTitle=精准打击！帕米帕利+贝伐珠单抗破解RAD50突变晚期卵巢透明细胞癌治疗难题, objectType=article, longId=804519, objectId=13f080451935, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301009/1696894120696_4754896.jpeg, objectUrl=/article/show_article.do?id=13f080451935, replyNumber=0, likeNumber=33, createdTime=2023-12-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=13f080451935, moduleTitle=精准打击！帕米帕利+贝伐珠单抗破解RAD50突变晚期卵巢透明细胞癌治疗难题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13f080451935)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1754395, encodeId=86ae1e54395d3, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=辅助放疗对早期卵巢透明细胞癌患者生存的影响, objectType=article, longId=724864, objectId=4eace2486473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eace2486473, replyNumber=0, likeNumber=35, createdTime=2022-09-10, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eace2486473, moduleTitle=辅助放疗对早期卵巢透明细胞癌患者生存的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eace2486473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754394, encodeId=458e1e5439482, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=CLIN CANCER RES：ENMD-2076治疗卵巢透明细胞癌, objectType=article, longId=156350, objectId=b0c5156350d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0c5156350d9, replyNumber=0, likeNumber=30, createdTime=2019-02-16, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0c5156350d9, moduleTitle=CLIN CANCER RES：ENMD-2076治疗卵巢透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0c5156350d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754392, encodeId=ceaf1e5439202, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例, objectType=article, longId=124873, objectId=cba21248e361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cba21248e361, replyNumber=0, likeNumber=46, createdTime=2018-06-15, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cba21248e361, moduleTitle=依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cba21248e361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754393, encodeId=d5be1e543930c, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=CLIN CANCER RES：mTORC1/2阻断可以用于治疗卵巢透明细胞癌, objectType=article, longId=147728, objectId=4fcc14e72887, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4fcc14e72887, replyNumber=0, likeNumber=34, createdTime=2018-11-02, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4fcc14e72887, moduleTitle=CLIN CANCER RES：mTORC1/2阻断可以用于治疗卵巢透明细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4fcc14e72887)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754391, encodeId=27d11e54391b8, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期), objectType=article, longId=73685, objectId=920ee368569, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920ee368569, replyNumber=0, likeNumber=36, createdTime=2016-07-25, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920ee368569, moduleTitle=JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920ee368569)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754390, encodeId=af941e543901a, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=ASCO 2014：PC与CPT-P方案一线治疗进展期卵巢透明细胞癌疗效相当, objectType=article, longId=36097, objectId=87e53609e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87e53609e2a, replyNumber=0, likeNumber=27, createdTime=2014-12-01, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87e53609e2a, moduleTitle=ASCO 2014：PC与CPT-P方案一线治疗进展期卵巢透明细胞癌疗效相当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87e53609e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754389, encodeId=db631e543896f, content=<a href='/topic/show?id=340b3688671' target=_blank style='color:#2F92EE;'>#卵巢透明细胞癌#</a>, objectTitle=晚期卵巢透明细胞癌姑息性化疗无明显获益, objectType=article, longId=2963, objectId=3015296366, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3015296366, replyNumber=0, likeNumber=31, createdTime=2011-08-28, rootId=0, userName=huangshifeng, userId=9ec436672078, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3015296366, moduleTitle=晚期卵巢透明细胞癌姑息性化疗无明显获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3015296366)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

卵巢透明细胞癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#贝伐珠单抗# #卵巢透明细胞癌# #帕米帕利#

精准打击！帕米帕利+贝伐珠单抗破解RAD50突变晚期卵巢透明细胞癌治疗难题

2023-12-11发表于上海

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

辅助放疗对早期卵巢透明细胞癌患者生存的影响

2022-09-10

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

CLIN CANCER RES：ENMD-2076治疗卵巢透明细胞癌

2019-02-16

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

依维莫司维持治疗原发性铂类耐药卵巢透明细胞癌一例

2018-06-15

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

CLIN CANCER RES：mTORC1/2阻断可以用于治疗卵巢透明细胞癌

2018-11-02

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

JCO：伊立替康+顺铂 vs 紫杉醇+卡铂一线治疗卵巢透明细胞癌(JGOG3017/GCIG 试验III期)

2016-07-25

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

ASCO 2014：PC与CPT-P方案一线治疗进展期卵巢透明细胞癌疗效相当

2014-12-01

huangshifeng (审核中...)

前往app查看评论内容

#卵巢透明细胞癌#

晚期卵巢透明细胞癌姑息性化疗无明显获益

2011-08-28

科室
- - 订阅+
  - 更多科室
工具
服务